Remove 2023 Remove FDA Remove Immunization
article thumbnail

FDA authorizes new drug to protect immune compromised from Covid-19

STAT

  The drug, known as Pemgarda and marketed by the biotech Invivyd, is the first such drug to become available since the agency pulled AstraZeneca’s Evusheld off the market in January 2023. New Omicron variants had rendered Evusheld ineffective. Read the rest…

article thumbnail

FDA approves Wezlana for inflammatory conditions

The Checkup by Singlecare

Food and Drug Administration (FDA) just approved Wezlana (ustekinumab-auub), a biosimilar for the popular drug Stelara. According to the FDA announcement, the most serious side effect of Wezlana is infection because the prescription affects your immune response.

FDA 110
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA approves Adstiladrin as first gene therapy for NMIBC

pharmaphorum

The US Food and Drug Administration (FDA) has approved Swiss drugmaker Ferring Pharmaceuticals’ Adstiladrin (nadofaragene firedenovec-vncg) for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with or without papillary tumours.

FDA 119
article thumbnail

Chasing Lilly, Concert eyes 2023 filing for its JAK drug for alopecia

pharmaphorum

If all goes well, CTP-543 could be ready for filing in early 2023, but even so it looks set to reach the AA market well behind Eli Lilly, which reported positive phase 3 results with its JAK 1/2 inhibitor Olumiant (baricitinib) earlier this year. Both Olumiant and CRP-543 have breakthrough designations from the FDA for this form of alopecia.

FDA 105
article thumbnail

Ampio slumps as FDA delivers knee osteoarthritis shock

pharmaphorum

Ampio Pharma’s candidate therapy for knee osteoarthritis has been knocked back by the FDA, which will likely now require a new clinical trial of the drug before it will consider a review. The FDA said it should have been advised of the proposed changes before Ampio unblinded and analysed the data from the AP-013 study.

FDA 111
article thumbnail

4 vitamins for post-COVID fatigue

The Checkup by Singlecare

Vitamin D Vitamin D coupons Most people think of vitamin D as the sunshine vitamin without realizing how big of an impact it has on our immune system. Low levels of vitamin D have been linked to poor immune function and fatigue, which can inhibit your recovery from COVID, says Simpson. Who should avoid vitamins for post-COVID fatigue?

article thumbnail

What was the most popular prescription in each state in 2023?

The Checkup by Singlecare

In 2023, nine drugs made our annual list of top prescriptions by state, with vitamin D being the most filled. Keep reading to find out which medications were filled with SingleCare the most in your state in 2023. People in the U.S. With two out of five Americans deficient in the nutrient, this ranking makes a lot of sense.